Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05656963
What this trial is testing

The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD

Who this might be right for
Glomerulonephritis, MembranousDiabetic NephropathiesThrombelastography+1 more
Yipeng Liu 741
Not applicableStudy completedNCT03148548
What this trial is testing

Substudy - Evaluation of Patients With Iliac Vein Thrombosis

Who this might be right for
Iliac Vein Thrombosis
Cardioangiologisches Centrum Bethanien 85
Not applicableUnknownNCT02731235
What this trial is testing

The Effect of Aerobic Exercise in Patients With Lacunar Stroke

Who this might be right for
Stroke, Lacunar
Herlev Hospital 71
Not applicableStudy completedNCT07805408
What this trial is testing

A Real World Study of Treatment Patterns and Effectiveness of Standard of Care in Primary Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia
Novartis Pharmaceuticals 3,714
Not applicableNot Yet RecruitingNCT07268898
What this trial is testing

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 500
Testing effectiveness (Phase 2)Looking for participantsNCT06929299
What this trial is testing

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Jiangsu BioJeTay Biotechnology Co., Ltd. 56
Not applicableStudy completedNCT03519672
What this trial is testing

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

Who this might be right for
Congenital Thrombotic Thrombocytopenic Purpura
Baxalta now part of Shire 41
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Large-scale testing (Phase 3)UnknownNCT05685420
What this trial is testing

Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 117
Early research (Phase 1)Study completedNCT03951623
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Hutchison Medipharma Limited 45
Testing effectiveness (Phase 2)Study completedNCT01107951
What this trial is testing

Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Hospital Universitario Dr. Jose E. Gonzalez 21
Large-scale testing (Phase 3)UnknownNCT05328804
What this trial is testing

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Yin Jie 90
Not applicableNot Yet RecruitingNCT07833254
What this trial is testing

Risk Factors of Venous Thrombotic Event in Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseVenous ThromboembolismPulmonary Embolism+1 more
Sohag University 100
Testing effectiveness (Phase 2)Study completedNCT02801032
What this trial is testing

Effect of Tadalafil on Cerebral Large Arteries in Stroke

Who this might be right for
Stroke, LacunarCerebral Small Vessel Diseases
Christina Kruuse 20
Not applicableUnknownNCT06098378
What this trial is testing

Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab

Who this might be right for
Thrombotic Microangiopathies
University Hospital, Strasbourg, France 30
Not applicableLooking for participantsNCT07016542
What this trial is testing

Cohort for Monitoring Patients With Venous Thromboembolic Disease

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Rouen 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05684159
What this trial is testing

Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy

Who this might be right for
aHUS - Atypical Hemolytic Uremic Syndrome
NovelMed Therapeutics 12
Not applicableStudy completedNCT04879550
What this trial is testing

Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO

Who this might be right for
Antithrombin III DeficiencyExtracorporeal Membrane Oxygenation Complication
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00770562
What this trial is testing

A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 103
Next Page